Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
The SUSTAIN-6 trial showed a significant reduction in major adverse cardiovascular events (MACE), including non-fatal myocardial infarction and non-fatal stroke, specifically in patients with type 2 diabetes and established cardiovascular disease or multiple cardiovascular risk factors
Nauck MA, Meier JJ, Cavender MA, Abd El Aziz M, Drucker DJ (2017) Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors
Ingredients & Contents
Eli Lilly markets Mounjaro as a powerful tool for managing type 2 diabetes and promoting weight loss, but reports have linked it to severe side effects such as stomach paralysis, vision loss, and deep vein thrombosis (DVT)
This imbalance can make muscles more prone to cramping and discomfort
US$ 25.40
US$ 23.59
US$ 29.61
